Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 168

1.

Angiogenesis facilitated by autologous whole bone marrow stem cell transplantation for Buerger's disease.

Kim DI, Kim MJ, Joh JH, Shin SW, Do YS, Moon JY, Kim NR, Lim JE, Kim AK, Eo HS, Kim BS, Cho SW, Yang SH, Park CJ, Shim JS.

Stem Cells. 2006 May;24(5):1194-200. Epub 2006 Jan 26.

2.

[A clinical study on implantation of autologous bone marrow mononuclear cells after bone marrow stimulation for treatment of lower limb ischemia].

Gu Y, Zhang J, Qi L.

Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2006 Oct;20(10):1017-20. Chinese.

PMID:
17140078
3.

Therapeutic angiogenesis in Buerger's disease (thromboangiitis obliterans) patients with critical limb ischemia by autologous transplantation of bone marrow mononuclear cells.

Motukuru V, Suresh KR, Vivekanand V, Raj S, Girija KR.

J Vasc Surg. 2008 Dec;48(6 Suppl):53S-60S; discussion 60S. doi: 10.1016/j.jvs.2008.09.005.

4.

Effect of autologous bone-marrow cell transplantation on ischemic ulcer in patients with Buerger's disease.

Saito Y, Sasaki K, Katsuda Y, Murohara T, Takeshita Y, Okazaki T, Arima K, Katsuki Y, Shintani S, Shimada T, Akashi H, Ikeda H, Imaizumi T.

Circ J. 2007 Aug;71(8):1187-92.

5.

Safety and efficacy of therapeutic angiogenesis as a novel treatment in patients with critical limb ischemia.

Lara-Hernandez R, Lozano-Vilardell P, Blanes P, Torreguitart-Mirada N, Galmés A, Besalduch J.

Ann Vasc Surg. 2010 Feb;24(2):287-94. doi: 10.1016/j.avsg.2009.10.012.

PMID:
20142004
6.

Treatment of thromboangiitis obliterans (Buerger's disease) by intramuscular gene transfer of vascular endothelial growth factor: preliminary clinical results.

Isner JM, Baumgartner I, Rauh G, Schainfeld R, Blair R, Manor O, Razvi S, Symes JF.

J Vasc Surg. 1998 Dec;28(6):964-73; discussion 73-5.

PMID:
9845647
7.

Clinical study of therapeutic angiogenesis by autologous peripheral blood stem cell (PBSC) transplantation in 92 patients with critically ischemic limbs.

Kawamura A, Horie T, Tsuda I, Abe Y, Yamada M, Egawa H, Iida J, Sakata H, Onodera K, Tamaki T, Furui H, Kukita K, Meguro J, Yonekawa M, Tanaka S.

J Artif Organs. 2006;9(4):226-33. Epub 2006 Dec 21.

PMID:
17171401
8.
9.

Changes in angiogenesis-related factors in serum following autologous bone marrow cell implantation for severe limb ischemia.

Tachi Y, Fukui D, Wada Y, Koshikawa M, Shimodaira S, Ikeda U, Amano J.

Expert Opin Biol Ther. 2008 Jun;8(6):705-12. doi: 10.1517/14712598.8.6.705 .

PMID:
18476781
10.

Autologous bone marrow transplantation and hyperbaric oxygen therapy for patients with thromboangiitis obliterans.

Saito S, Nishikawa K, Obata H, Goto F.

Angiology. 2007 Aug-Sep;58(4):429-34. Epub 2007 Jul 24.

PMID:
17652224
11.

Autologous peripheral blood mononuclear cell implantation for patients with peripheral arterial disease improves limb ischemia.

Ishida A, Ohya Y, Sakuda H, Ohshiro K, Higashiuesato Y, Nakaema M, Matsubara S, Yakabi S, Kakihana A, Ueda M, Miyagi C, Yamane N, Koja K, Komori K, Takishita S.

Circ J. 2005 Oct;69(10):1260-5.

12.

Therapeutic angiogenesis of bone marrow mononuclear cells (MNCs) and peripheral blood MNCs: transplantation for ischemic hindlimb.

Zhang H, Zhang N, Li M, Feng H, Jin W, Zhao H, Chen X, Tian L.

Ann Vasc Surg. 2008 Mar;22(2):238-47. Epub 2008 Feb 20.

PMID:
18083329
13.

Stem cell therapy: a promising and prospective approach in the treatment of patients with severe Buerger's disease.

Boda Z, Udvardy M, Rázsó K, Farkas K, Tóth J, Jámbor L, Oláh Z, Ilonczai P, Szarvas M, Kappelmayer J, Veréb Z, Rajnavölgyi E.

Clin Appl Thromb Hemost. 2009 Oct;15(5):552-60. doi: 10.1177/1076029608319882. Epub 2008 Sep 25.

PMID:
18818231
14.

[Therapeutic angiogenesis for patients with critical limb ischemia using autologous bone marrow cell transplantation].

Matsubara H.

Nihon Naika Gakkai Zasshi. 2003 May 10;92(5):877-83. Review. Japanese. No abstract available.

PMID:
12808915
15.

Unblinded pilot study of autologous transplantation of bone marrow mononuclear cells in patients with thromboangiitis obliterans.

Miyamoto K, Nishigami K, Nagaya N, Akutsu K, Chiku M, Kamei M, Soma T, Miyata S, Higashi M, Tanaka R, Nakatani T, Nonogi H, Takeshita S.

Circulation. 2006 Dec 12;114(24):2679-84. Epub 2006 Dec 4.

16.

Safety and efficacy of autologous bone marrow stem cell transplantation through hepatic artery for the treatment of chronic liver failure: a preliminary study.

Khan AA, Parveen N, Mahaboob VS, Rajendraprasad A, Ravindraprakash HR, Venkateswarlu J, Rao SG, Narusu ML, Khaja MN, Pramila R, Habeeb A, Habibullah CM.

Transplant Proc. 2008 May;40(4):1140-4. doi: 10.1016/j.transproceed.2008.03.111.

PMID:
18555134
17.

Letter by Akar et al regarding article, "Effect of autologous bone-marrow cell transplantation on ischemic ulcer in patients with Buerger's disease".

Akar AR, Durdu S, Baran C.

Circ J. 2008 Apr;72(4):684; author reply 685-6. No abstract available.

PMID:
18362447
18.

Transplantation of autologous bone marrow mononuclear cells for patients with lower limb ischemia.

Gu YQ, Zhang J, Guo LR, Qi LX, Zhang SW, Xu J, Li JX, Luo T, Ji BX, Li XF, Yu HX, Cui SJ, Wang ZG.

Chin Med J (Engl). 2008 Jun 5;121(11):963-7.

PMID:
18706241
19.

Effects of granulocyte colony simulating factor on functional activities of endothelial progenitor cells in patients with chronic ischemic heart disease.

Honold J, Lehmann R, Heeschen C, Walter DH, Assmus B, Sasaki K, Martin H, Haendeler J, Zeiher AM, Dimmeler S.

Arterioscler Thromb Vasc Biol. 2006 Oct;26(10):2238-43. Epub 2006 Aug 10.

Supplemental Content

Support Center